Merissa Brousseau

Merissa Brousseau

Auto-generated profile, based on publicly available information

Merissa Brousseau

Department of Biochemistry, University of Wisconsin-Madison

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPeyton J. Spreacker
Peyton J. Spreacker
NTNathan E. Thomas
Nathan E. Thomas
WBWill F. Beeninga
Will F. Beeninga
MBMerissa Brousseau
Merissa Brousseau
CPColin J. Porter
Colin J. Porter
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
Small multidrug resistance (SMR) transporters contribute to antibiotic resistance through proton-coupled efflux of toxic compounds. Previous biophysical studies of the E. coli SMR transporter EmrE suggest that it should also be able to perform proton/toxin symport or uniport, leading to toxin susceptibility rather than resistance in vivo. Here we show EmrE does confer susceptibility to several previously uncharacterized small-molecule substrates in E. coli, including harmane. In vitro electrophysiology assays demonstrate that harmane binding triggers uncoupled proton flux through EmrE. Assays in E. coli are consistent with EmrE-mediated dissipation of the transmembrane pH gradient as the mechanism underlying the in vivo phenotype of harmane susceptibility. Furthermore, checkerboard assays show this alternative EmrE transport mode can synergize with some existing antibiotics, such as kanamycin. These results demonstrate that it is possible to not just inhibit multidrug efflux, but to activate alternative transport modes detrimental to bacteria, suggesting a strategy to address antibiotic resistance.

25 April 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ASAlexander A. Shcherbakov
Alexander A. Shcherbakov
MBMerissa Brousseau
Merissa Brousseau
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
MHMei Hong
Mei Hong

7 July 2025 in eLife
Verified
Journal Article
Open access
MBMerissa Brousseau
Merissa Brousseau
DTDa Teng
Da Teng
NTNathan E Thomas
Nathan E Thomas
GVGregory Voth
Gregory Voth
KHKatherine A Henzler-Wildman
Katherine A Henzler-Wildman
The model multi-drug efflux pump from Escherichia coli, EmrE, can perform multiple types of transport leading to different biological outcomes, conferring resistance to some drug substrates and enhancing susceptibility to others. While transporters have traditionally been classified as antiporters, symporters, or uniporters, there is growing recognition that some transporters may exhibit mixed modalities. This raises new questions about their regulation and mechanism. Here, we show that the C-terminal tail of EmrE acts as a secondary gate, preventing proton leak in the absence of drug. Substrate binding unlocks this gate, allowing transport to proceed. Truncation of the C-terminal tail (∆107-EmrE) leads to altered pH regulation of alternating access, an important kinetic step in the transport cycle, as measured by NMR. ∆107-EmrE has increased proton leak in proteoliposomes, and bacteria expressing this mutant have reduced growth. Molecular dynamics simulations of ∆107-EmrE show the formation of a water wire from the open face of the transporter to the primary binding site in the core, facilitating proton leak. In WT-EmrE, the C-terminal tail forms specific interactions that block the formation of the water wire. Together, these data strongly support the C-terminus of EmrE acting as a secondary gate that regulates access to the primary binding site.

3 September 2025 in Biochemistry
Verified
Journal Article
Open access
MBMerissa Brousseau
Merissa Brousseau
TDTapasyatanu Dash
Tapasyatanu Dash
MRMichael J. Rourke
Michael J. Rourke
VKVilius Kurauskas
Vilius Kurauskas
MTMarco Tonelli
Marco Tonelli
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
The recent discovery that the model multidrug efflux pump from Escherichia coli, EmrE, can perform multiple types of transport suggests that this may be a compelling target for therapeutic intervention. Initial studies have identified several small-molecule substrates capable of inducing transporter-dependent susceptibility rather than the well-known antibiotic resistance phenotype. However, many questions regarding the underlying mechanism and regulation of this transporter still remain. Prior studies identified lysine 22 as well as threonine 56 as important residues for regulating the formation of an occluded state critical to the prevention of an uncoupled leak in the WT transporter. Here, we use NMR chemical shift perturbations and in vivo EC50 assays to confirm that 18-crown-6-ether binds at lysine 22, while liposomal leak assays verify that this substrate triggers uncoupled proton leak. In addition to characterizing the mechanism of action of another susceptibility substrate for EmrE, the characterization of K22 mutants herein solidifies the importance of this residue, as well as the nearby residue T56, in the allosteric regulation of the C-terminal tail. With a high degree of familial conservation in addition to a suggested role in transporter evolution, mechanistic insight into the transport regulation of EmrE may be broadly applicable across small multidrug-resistant efflux pumps.

30 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAshley B. Hiett-Borcik
Ashley B. Hiett-Borcik
BHBenjamin D. Harding
Benjamin D. Harding
MBMerissa Brousseau
Merissa Brousseau
OWOwen Warmuth
Owen Warmuth
CBCollin G. Borcik
Collin G. Borcik
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
The multidrug efflux pump EmrE is one of the smallest known active transporters and has become a model system for studying multidrug recognition and transport. While recent high-resolution structures have illuminated its dynamic substrate binding pocket, the conformations of its interhelical loops and C-terminal tail, regions critical for controlling proton coupling and gating, remain poorly characterized. Here, we report the high-resolution structure of protonated S64V EmrE determined using solution and solid-state NMR data. This new structural model shows the C-terminal tail occluding the open face of the transport pore, providing a structural basis for how EmrE minimizes proton leak in the absence of substrate. These findings support growing evidence that relatively simple model transporters must leverage an occluded state during alternating access to avoid physiologically unfavorable proton leak.